dr. jason luke discusses nivolumab and pembrolizumab in melanoma
Published 9 years ago • 678 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
0:52
dr. luke discusses the combination of epacadostat and pembrolizumab in melanoma
-
1:57
dr. luke discusses the controversy surrounding ipilimumab/nivolumab combo in melanoma
-
1:09
dr. jason luke talks about advances in how melanoma is diagnosed
-
1:04
dr. luke on the combination of pembrolizumab and t-vec for melanoma
-
1:41
dr. luke discusses combination approaches on horizon in melanoma
-
2:05
dr. luke on challenges with immunotherapy in melanoma
-
1:06
dr. luke on the future role of immunotherapy combinations in melanoma
-
1:49
dr. luke on the fda approval of adjuvant nivolumab in melanoma
-
3:40
out of the shadows - a mucosal melanoma awareness video
-
23:01
the effects of melatonin on cancer | dr. nathan goodyear at brio-medical alternative cancer clinic
-
8:05
this revolutionary treatment kills cancer from the inside out
-
4:25
the phenomenon of immunotherapy in melanoma
-
0:43
keynote-716: adjuvant pembrolizumab for high-risk melanoma
-
1:51
dr. luke on immunotherapy diagnostics in melanoma
-
1:30
dr. jason luke on sequencing targeted and immunotherapy agents in braf melanoma
-
1:25
dr. jason luke on potential for ido inhibitors in melanoma
-
1:01
dr. luke on the future of combination therapy in melanoma
-
1:00
dr. sznol on immune-related toxicities in melanoma
-
1:26
dr. jason luke discusses the giants of cancer care program
-
1:14
dr. luke on the clinical trial landscape for melanoma
-
1:20
dr. luke on immunotherapy advancements in melanoma
-
1:10
dr. luke on ongoing studies with immunotherapy in melanoma